Home » Stocks » GMED

Globus Medical, Inc. (GMED)

Stock Price: $71.20 USD 0.15 (0.21%)
Updated May 11, 2021 4:00 PM EDT - Market closed
Market Cap 7.14B
Revenue (ttm) 825.81M
Net Income (ttm) 121.67M
Shares Out 99.87M
EPS (ttm) 1.20
PE Ratio 59.19
Forward PE 38.76
Dividend n/a
Dividend Yield n/a
Trading Day May 11
Last Price $71.20
Previous Close $71.05
Change ($) 0.15
Change (%) 0.21%
Day's Open 70.00
Day's Range 69.51 - 71.67
Day's Volume 432,885
52-Week Range 42.85 - 73.74

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Globus Medical (GMED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

5 days ago - Zacks Investment Research

Take a look at these Reddit stocks that are far from speculative. These seven have strong underlying business fundamentals and can be long-term value creators.

Other stocks mentioned: AAPL, GME, MC, NOK, OCGN, TSLA
5 days ago - InvestorPlace

Globus Medical's (GMED) first-quarter 2021 revenues improved year over year on strength in Enabling Technologies and U.S. Spine.

6 days ago - Zacks Investment Research

Globus Medical (GMED) delivered earnings and revenue surprises of 36.11% and 15.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Shares of Globus Medical (NYSE:GMED) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 68.97% year over year to $0.49, which beat th...

1 week ago - Benzinga

AUDUBON, Pa., May 04, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2021.

1 week ago - GlobeNewsWire

AUDUBON, Pa., April 21, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, ...

2 weeks ago - GlobeNewsWire

Globus Medical's (GMED) latest development to robotically navigated spine surgery will enable surgeons to maintain the navigational accuracy without performing traditional pedicle preparation.

3 weeks ago - Zacks Investment Research

The Latest Enhancement to Robotically Navigated Spine Surgery with ExcelsiusGPS® The Latest Enhancement to Robotically Navigated Spine Surgery with ExcelsiusGPS®

3 weeks ago - GlobeNewsWire

Pricing continues to remain a major headwind for Globus Medical (GMED).

1 month ago - Zacks Investment Research

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

Globus Medical's (GMED) spinal implant business performance varies by region in Q4.

2 months ago - Zacks Investment Research

Globus Medical (GMED) delivered earnings and revenue surprises of 13.73% and -0.34%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Globus Medical (NYSE:GMED) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 18.37% over the past year to $0.58, which beat the e...

2 months ago - Benzinga

AUDUBON, Pa., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ende...

2 months ago - GlobeNewsWire

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

AUDUBON, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year en...

3 months ago - GlobeNewsWire

Globus Medical's (GMED) recent product launches are seeing tremendous uptake.

3 months ago - Zacks Investment Research

Globus Medical (GMED) saw a visible rebound in its revenue trend in the third quarter.

4 months ago - Zacks Investment Research

Globus Medical: Entry At The Pullback Paid Off, Upside On Entry Today Equally Exciting

4 months ago - Seeking Alpha

AUDUBON, Pa., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, was recently awarded a group purchasing agreement with Premier, one of the ...

5 months ago - GlobeNewsWire

Investors continue to be optimistic about Globus Medical (GMED) on robust product uptake and prominent sales trend improvement in the third quarter.

5 months ago - Zacks Investment Research

Globus Medical (GMED) is optimistic about maintaining robust product portfolio along with strength in its domestic spine business.

5 months ago - Zacks Investment Research

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

New ExcelsiusGPS® Interbody Solutions module expands system for planning and navigating the entire interbody fusion procedure New ExcelsiusGPS® Interbody Solutions module expands system for planning and...

5 months ago - GlobeNewsWire

Globus Medical's (GMED) spinal implant business performance varies by region in Q3.

6 months ago - Zacks Investment Research

Globus Medical, Inc. (GMED) CEO Dave Demski on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Globus Medical (GMED) delivered earnings and revenue surprises of 58.06% and 9.30%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

AUDUBON, Pa., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, ...

6 months ago - GlobeNewsWire

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

AUDUBON, Pa., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 3...

6 months ago - GlobeNewsWire

Globus Medical Has Reached The 10% Pullback We Were Hoping For - Time For Entry

7 months ago - Seeking Alpha

Investors continue to be optimistic about Globus Medical (GMED) on robust product uptake and prominent sales trend improvement since the second quarter.

7 months ago - Zacks Investment Research

AUDUBON, Pa., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate as a platinum sponsor at the North Amer...

7 months ago - GlobeNewsWire

Robotics stocks offer great opportunities for growth investors and recent adoptions have accelerated the industry's growth rapidly.

Other stocks mentioned: ABB, BRKS, TER
7 months ago - Zacks Investment Research

A Relative Strength Rating upgrade for Globus Medical shows improving technical performance. Will it continue?

8 months ago - Investors Business Daily

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

8 months ago - Zacks Investment Research

Globus Medical is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

8 months ago - Zacks Investment Research

Globus Medical (GMED) witnesses a significant rebound from mid-April through the remainder of Q2.

8 months ago - Zacks Investment Research

Globus Medical Climbs 18.12% From Q2 Exit - Beats EPS By $0.18; But Let's Not Jump In Just Yet

9 months ago - Seeking Alpha

Globus Medical (GMED) witnesses dismal segmental and international performance in the second quarter owing to pandemic-led adversities.

9 months ago - Zacks Investment Research

The medical device maker reported second-quarter results that were much better than expected.

9 months ago - The Motley Fool

Globus Medical, Inc. (GMED) CEO Dave Demski on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Globus Medical (GMED) delivered earnings and revenue surprises of 163.64% and 49.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

AUDUBON, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June ...

9 months ago - GlobeNewsWire

Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

Health care is supposed to be a very defensive sector in investing. After all, diseases and conditions such as cancer, diabetes, heart disease, kidney failure, dementia, joint damage and spinal issues a...

Other stocks mentioned: ABT, BAX, BSX, EW, JNJ, MDT, NUVA ...
9 months ago - 24/7 Wall Street

AUDUBON, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended June 30, ...

9 months ago - GlobeNewsWire

Big data is becoming a big factor in the healthcare industry.

Other stocks mentioned: CERN, HCAT
10 months ago - The Motley Fool

Robotics stocks offer multi-decade growth potential. These 10 stocks offer some of the best exposure to this attractive trend.

Other stocks mentioned: ABB, AVAV, BOTZ, FLIR, IRBT, ISRG, STXS ...
10 months ago - InvestorPlace

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventio... [Read more...]

Industry
Medical Devices
IPO Date
Aug 3, 2012
CEO
David Demski
Employees
2,200
Stock Exchange
NYSE
Ticker Symbol
GMED
Full Company Profile

Financial Performance

In 2020, Globus Medical's revenue was $789.04 million, an increase of 0.47% compared to the previous year's $785.37 million. Earnings were $102.29 million, a decrease of -34.10%.

Financial Statements

Analyst Forecasts

According to 16 analysts, the average rating for Globus Medical stock is "Buy." The 12-month stock price forecast is 77.73, which is an increase of 9.17% from the latest price.

Price Target
$77.73
(9.17% upside)
Analyst Consensus: Buy